Hilco are pleased to offer for sale the business and assets of a UK Healthcare IT software and hardware provider to primary, secondary and community care practices. The business has significant potential to expand and diversify its clinical solutions across the UK healthcare marketplace.
Market Opportunity
An opportunity to become one of the main providers of GP Healthcare IT solutions in the UK
Offering diversification possibilities into private healthcare, prison, and hospital settings
Ongoing product development in Digital Prescribing & Digital Pathways (DPDP) applications
Prospects to pursue document management interface solution for repository of digital and scanned records
Further enhancement of the medical data collection scheme to provide healthcare professionals, authorities, research organisations and academics with healthcare research and analysis
Acquisition will enable the acquirer to become a major player in the UK marketplace for a fraction of the investment that would otherwise be required
Company Highlights
Healthcare IT solution with broad interoperability hosting a cloud native and agnostic model
Customer base of 780+ GP practices across all 4 UK Countries
Continued migration of healthcare IT solution into NHS GP Practices
One of 3 dominant Technology and Data partners for the NHS primary care, Prison System, MHRA and academic organisations in the UK
Accomplished management and a skilled technical team with extensive experience in healthcare technology
Extensive intellectual property and significant brand equity
c.£35m of investments into next generation software (75% readiness)
£12.7m total revenue forecast for 2024
Sale Process and Further Information
Deadline for expressions of interest is Friday 24 January 2025, 12pm noon GMT.
On receipt of a signed non-disclosure agreement (NDA) access will be provided to a virtual data room housing additional information. To access the NDA please click the link, sign and return via email to apercival@hilcoglobaladvisors.co.uk
Terms and Conditions
No warranties, express or implied, are provided in relation to any information or statements made in connection to this opportunity. The information contained herein, and within the project dataroom, has not been verified by Hilco and prospective purchasers must undertake their own due diligence to satisfy themselves as to the accuracy of all such information and any statements made. Hilco’s full Terms and Conditions apply. Hilco acts as agent for the Vendor who offers for sale only such right, title and interest the Company possesses in the assets.
